Etodolac Tablet, Film Coated
Product Images NDC 51672-4036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 51672-4036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taro Pharmaceuticals U.s.a., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Etodolac 01)

FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

Principal Display Panel (200 mg Capsule Bottle Label)
Each capsule of this medication contains 200 mg of etodolac. The medication comes in a bottle of 100 capsules, and it is important to read the accompanying Medication Guide. The package insert should also be referred to for the correct dosage. The medication should be stored in a cool and dry place at a temperature of 20 to 25°C. The manufacturer is Taro Pharmaceutical Industries Ltd, located in Haifa Bay, Israel, and it is distributed in the United States by Taro Pharmaceuticals U.S.A., Inc. This medication is only available with a prescription.*
FDA Label Image

Principal Display Panel (300 mg Capsule Bottle Label)

Principal Display Panel (300 mg Capsule Bottle Label)
Each capsule of this medication contains 300 milligrams of etodolac and is packaged in a container with 100 capsules. The medication guide should be read before use. The recommended dosage is indicated in the package insert. The medication should be stored in a tightly closed container at a controlled room temperature of 20° to 25°C. The medication is produced by Taro Pharmaceutical Industries Ltd and distributed by Taro Pharmaceuticals USA Inc. This medication is prescription-only and should be used with appropriate caution.*
FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Principal Display Panel (400 mg Tablet Bottle Label)
NDC 51672-4018-1 is a sealed prescription of 100 tablets of Etodolac, each tablet containing 400mg of the drug. The package must be stored between 20° to 25°C (68° to 77°F), protected from moisture, and in a tight container. The manufacturer, Taro Pharmaceutical Industries Ltd., is based in Haifa Bay, Israel, while distribution of the drug is handled by Taro Pharmaceuticals U.S.A., Inc. The package insert should be followed for full prescribing information, and a Medication Guide should accompany the drug.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
This is a medication called Etodolac in tablet form. The package contains 100 tablets and the National Drug Code (NDC) is 51672-4036-1. Each tablet contains a certain amount of the active ingredient. The accompanying medication guide should be used by the pharmacist when dispensing. The full prescribing information can be found in the package insert. The medication should be stored in a cool, dry place, between 20° and 25°C (68° to 77°F) and in a tightly sealed container. The manufacturer is Taro Pharmaceutical Industries Ltd. located in Haifa Bay, Israel, and the distributor is not specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.